↓ Skip to main content

Cochrane Database of Systematic Reviews

Interventions for HIV-associated nephropathy

Overview of attention for article published in Cochrane database of systematic reviews, January 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

f1000
1 research highlight platform

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
94 Mendeley
citeulike
1 CiteULike
Title
Interventions for HIV-associated nephropathy
Published in
Cochrane database of systematic reviews, January 2013
DOI 10.1002/14651858.cd007183.pub3
Pubmed ID
Authors

Ismail Yahaya, Olalekan A Uthman, Muhammed Mubashir B Uthman

Abstract

Human immunodeficiency virus-associated nephropathy (HIVAN) is the most common cause of end stage kidney disease (ESKD) in human immunodeficiency virus-1 (HIV-1) serotype patients and it mostly affects patients of African descent. It rapidly progresses to ESKD if untreated. The goal of treatment is directed toward reducing HIV-1 replication and/or slowing the progression of chronic kidney disease. The following pharmacological agents have been used for the treatment of HIVAN: antiretroviral therapy, angiotensin-converting enzyme inhibitors (ACEi), steroids and recently cyclosporin. Despite this, the effect of each intervention is yet to be evaluated.

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 94 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 24%
Student > Bachelor 12 13%
Student > Postgraduate 11 12%
Student > Ph. D. Student 11 12%
Researcher 8 9%
Other 13 14%
Unknown 16 17%
Readers by discipline Count As %
Medicine and Dentistry 45 48%
Nursing and Health Professions 10 11%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Social Sciences 3 3%
Immunology and Microbiology 2 2%
Other 11 12%
Unknown 20 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2013.
All research outputs
#7,860,076
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#7,817
of 8,923 outputs
Outputs of similar age
#77,545
of 143,900 outputs
Outputs of similar age from Cochrane database of systematic reviews
#82
of 102 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 143,900 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.